Mesoblast Limited (MESO) Social Stream



Mesoblast Limited (MESO): $2.60

0.15 (+6.12%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Mesoblast Ltd (MESO) Price Targets From Analysts

Use the tables below to see what analysts covering Mesoblast Ltd think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-24 6 $23 $6.5 $15.9 $4.32 268.06%
2022-02-25 4 $23 $6.5 $15.9 $4.32 268.06%
2022-02-28 5 $23 $6.5 $15.9 $4.32 268.06%

The Trend in the Analyst Price Target


MESO's average price target has moved down $0.92 over the prior 21 months.

Over the past 178 days, MESO's average upside potential has been 214.3%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-03 6 23 6.5 15.9 6.37 149.61%
2021-11-24 4 23 6.5 15.9 6.38 149.22%
2022-01-31 4 23 6.5 15.9 4.04 293.56%
2022-02-25 4 23 6.5 15.9 3.97 300.5%
2022-02-28 5 23 6.5 15.9 3.89 308.74%

MESO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations


Over the past 16 months, MESO's average broker recommendation rating improved by 0.35.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, Mesoblast Ltd's variance in analysts' estimates is lower than -179.03% of them.
  • In terms of how Mesoblast Ltd fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 275.28% of that group.
  • In terms of how Mesoblast Ltd fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 44.52% of that group.
  • In the context of stocks in the mid market cap category, Mesoblast Ltd's number of analysts covering the stock is greater than 78.94% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Mesoblast Ltd are KYMR, KOD, and IOVA.

What is the outlook for MESO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4816 seconds.